Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines
Guy de Bruyn, Joyce Wang, Annie Purvis, Martin Sanchez Ruiz, Haritha Adhikarla, Saad Alvi, Matthew I Bonaparte, Daniel Brune, Agustin Bueso, Richard M Canter, Maria Angeles Ceregido, David Diemert, Adam Finn, Remi Forrat, Bo Fu, Julie Gallais, Paul Griffin, Marie-Helene Grillet, Owen Haney, Jeffrey A Henderson, Marguerite Koutsoukos, Odile Launay, Federico Martinon Torres, Roger Masotti, Nelson L Michael, Juliana Park, Doris M Rivera, Natalya Romanyak, Chris Rook, Lode Schuerman, Lawrence D Sher, Fernanda Tavares-Da-Silva Sachin Deshmukh, Ashley Whittington, Roman M Chicz, Sanjay Gurunathan, Stephen Savarino, Saranya Sridhar, VAT00002 booster cohorts study team
medRxiv 2022.12.02.22282931; doi: https://doi.org/10.1101/2022.12.02.22282931
